Skip to content

APOTHEEK TEMPELHOF

Active
Private limited companyfounded 199828 yrs activeDiestsestraat 223, 3000 Leuven, BelgiumKBO/BCE: BE 0464.032.162

APOTHEEK TEMPELHOF has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €111k and a net result of €45k. Equity is growing by ~23.6% per year across the filed fiscal years. Its solvency ranks better than 75% of 10289 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Checked score

Score 2025
83 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+24
Solvency87▲+26
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 2.37 against 1.37 in 2024; short-term debt: 37.7% and cash: 12.6% of total assets), and 37.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 28 years 0 30 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
62.3%
Return on assets
25.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
28 d early
2024
7 d early
2023
29 d late
2022
31 d early
2021
20 d late
2020
30 d late
2019
28 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€111k▲ 67.6%
2024 · €66k
2018: €28k 2019: €29k 2020: €21k 2021: €22k 2022: €39k 2023: €56k 2024: €66k
2018 → 2025
Total assets
€177k▼ 2.4%
2024 · €182k
2018: €209k 2019: €194k 2020: €198k 2021: €199k 2022: €219k 2023: €211k 2024: €182k
2018 → 2025
Net result
€45k▲ 336%
2024 · €10k
2018: €-5k 2019: €912 2020: €-8k 2021: €941 2022: €17k 2023: €16k 2024: €10k
2018 → 2025
Working capital
€92k▲ 118%
2024 · €42k
2018: €5k 2019: €5k 2020: €831 2021: €8k 2022: €18k 2023: €33k 2024: €42k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€22k-€39k▲ 80.0%€56k▲ 41.9%€66k▲ 18.3%€111k▲ 67.6%
Operating result€-404-€20k€21k▲ 5.6%€13k▼ 38.4%€59k▲ 348%
Net result€941-€17k▲ 1,755%€16k▼ 5.8%€10k▼ 37.9%€45k▲ 336%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-20k€0€20k€40k€60kOperating result 2021: €-404€-404Net result 2021: €941€941Operating result 2022: €20k€20kNet result 2022: €17k€17kOperating result 2023: €21k€21kNet result 2023: €16k€16kOperating result 2024: €13k€13kNet result 2024: €10k€10kOperating result 2025: €59k€59kNet result 2025: €45k€45k20212022202320242025
The operating result recovers in 2025; 2025 is 348% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €177k
Fixed assets €19k▼ 25.4%
Current assets €158k▲ 1.4%
Equity and liabilities €177k
Equity €111k▲ 67.6%
Debt €67k▼ 42.2%
The debt ratio falls from 63.7% to 37.7%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€69k
2024 · €23k
Cash flow
€55k
2024 · €20k
Solvency
62.3%
2024 · 36.3%
Current ratio
2.37
2024 · 1.37
Quick ratio
1.05
2024 · 0.62
Debt / equity
0.60
2024 · 1.76
ROE
40.3%
2024 · 15.5%
ROA
25.1%
2024 · 5.6%
Interest coverage
18135.02
2024 · 345.74
Debt
€67k
2024 · €116k
Debt ≤ 1 year
€67k
2024 · €114k
Income taxes
€15k
2024 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€182k€177k
Fixed assets21/28€26k€19k
Tangible fixed assets22/27€21k€15k
Plant, machinery and equipment23€7k€8k
Furniture and vehicles24€336€117
Other tangible fixed assets26€13k€6k
Financial fixed assets28€5k€5k=
Current assets29/58€156k€158k
Stocks and contracts in progress3€85k€88k
Stocks30/36€85k€88k
Amounts receivable within one year40/41€40k€42k
Trade receivables40€35k€37k
Other amounts receivable41€5k€5k
Cash at bank and in hand54/58€24k€22k
Deferred charges and accrued income490/1€6k€6k
Equity and liabilities
Total equity and liabilities10/49€182k€177k
Equity10/15€66k€111k
Contributions10/11€19k€19k=
Reserves13€47k€92k
Distributable reserves133€47k€92k
Amounts payable17/49€116k€67k
Amounts payable after more than one year17€1k-
Financial debts170/4€1k-
Amounts payable within one year42/48€114k€67k
Trade debts44€13k€36k
Suppliers440/4€13k€36k
Taxes, remuneration and social security45€1k€131
Taxes450/3€1k€131
Other amounts payable47/48€100k€31k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€10k
Other operating charges640/8€472€487
Gross operating margin9900€24k€69k
Operating profit (loss)9901€13k€59k
Financial income75/76B€1k€1k
Recurring financial income75€1k€1k
Financial charges65/66B€67€4
Recurring financial charges65€67€4
Profit (loss) for the period before taxes9903€14k€60k
Income taxes67/77€4k€15k
Profit (loss) for the period9904€10k€45k
Profit (loss) for the period to be appropriated9905€10k€45k
Appropriation of the result
Profit (loss) to be appropriated9906€10k€45k
Transfer to equity691/2€10k€45k
To other reserves6921€10k€45k

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
03-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Highest result since 2018net €45k ▲336%
Operating result €59k, net result €45k, both a record.
31-12
Financial Equity above €100kEq €111k ▲67.6%
5 profitable years in a row build equity to €111k.
24-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
29-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
30-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
20-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 20 days late
2021
31-12
Financial Back to profitnet €941
Net result €941 after one loss-making year.
30-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 30 days late
2020
31-12
Financial Weakest financial yearnet €-8k ▼942%
Net result drops to €-8k, the lowest in the series; recovery starts the following year.
28-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 28 days late
2019
31-12
Financial Back to profitnet €912
Net result €912 after one loss-making year.
28-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 28 days late
2018
08-10
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
21-03
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 1998
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Diestsestraat 2233000 Leuven
Ground area
87 m²
Building footprint
86 m²
Volume, LiDAR
1,098 m³
Parcel 24062A0979/00D000, Flanders · tallest building 14.7 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK
Diestsestraat 223, 3000 LeuvenWarehousing and support activities for transportation
since 19982.089.570.931
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24062A0979/00D000 Flanders 87 m² 1 · 86 m² 14.7 m · 5 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Leuven2.089.570.931
1 permission
Apotheek (LM>3 maand) · since 01-01-2006

Similar companies · same sector, comparable size

Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,453 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded25-08-1998
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 28 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.